Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2017

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2017
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2017
The figures have not been audited

Attachments

PHARMA 0917-Q3.pdf
344.1 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2017

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2017
30 Sep 2016
30 Sep 2017
30 Sep 2016
$$'000
$$'000
$$'000
$$'000
1 Revenue
574,503
515,215
1,710,764
1,606,206
2 Profit/(loss) before tax
15,271
19,923
53,198
67,948
3 Profit/(loss) for the period
3,890
12,648
32,899
46,759
4 Profit/(loss) attributable to ordinary equity holders of the parent
3,580
13,061
32,023
46,435
5 Basic earnings/(loss) per share (Subunit)
1.38
5.04
12.34
17.93
6 Proposed/Declared dividend per share (Subunit)
5.00
4.00
13.00
13.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.0500
2.0500

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 15 Nov 2017
Category Financial Results
Reference Number FRA-31102017-00002